0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Myasthenia Gravis Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-28J3997
Home | Market Reports | People & Society
Global and United States Myasthenia Gravis Market Size Status and Forecast 2021 2027

Global and United States Myasthenia Gravis Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-28J3997
Report
September 2021
106 Pages
QYResearch
Region: Global, North America, Europe, France, Canada, Germany, Italy, UAE, Turkey, Saudi Arabia, Southeast Asia, Russia, South Korea,
Description
Table of Content
Tables & Figures
Global Myasthenia Gravis Scope and Market Size
Myasthenia Gravis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Myasthenia Gravis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Drug Treatment
Rapid Immunotherapies

Segment by Application

Hospitals
Clinics
Other

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

Takeda
F. Hoffmann-La Roche
CSL Behring
Grifols
Alexion Pharmaceutical
Avadel Pharmaceuticals
Baxter International
Novartis
Bausch Health
Takeda Pharmaceutical Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Rapid Immunotherapies
1.3 Market by Application
1.3.1 Global Myasthenia Gravis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Myasthenia Gravis Market Perspective (2016-2027)
2.2 Myasthenia Gravis Growth Trends by Regions
2.2.1 Myasthenia Gravis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Myasthenia Gravis Historic Market Share by Regions (2016-2021)
2.2.3 Myasthenia Gravis Forecasted Market Size by Regions (2022-2027)
2.3 Myasthenia Gravis Industry Dynamic
2.3.1 Myasthenia Gravis Market Trends
2.3.2 Myasthenia Gravis Market Drivers
2.3.3 Myasthenia Gravis Market Challenges
2.3.4 Myasthenia Gravis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Myasthenia Gravis Players by Revenue
3.1.1 Global Top Myasthenia Gravis Players by Revenue (2016-2021)
3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2016-2021)
3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Myasthenia Gravis Revenue
3.4 Global Myasthenia Gravis Market Concentration Ratio
3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2020
3.5 Myasthenia Gravis Key Players Head office and Area Served
3.6 Key Players Myasthenia Gravis Product Solution and Service
3.7 Date of Enter into Myasthenia Gravis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Breakdown Data by Type
4.1 Global Myasthenia Gravis Historic Market Size by Type (2016-2021)
4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2022-2027)
5 Myasthenia Gravis Breakdown Data by Application
5.1 Global Myasthenia Gravis Historic Market Size by Application (2016-2021)
5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Myasthenia Gravis Market Size (2016-2027)
6.2 North America Myasthenia Gravis Market Size by Type
6.2.1 North America Myasthenia Gravis Market Size by Type (2016-2021)
6.2.2 North America Myasthenia Gravis Market Size by Type (2022-2027)
6.2.3 North America Myasthenia Gravis Market Size by Type (2016-2027)
6.3 North America Myasthenia Gravis Market Size by Application
6.3.1 North America Myasthenia Gravis Market Size by Application (2016-2021)
6.3.2 North America Myasthenia Gravis Market Size by Application (2022-2027)
6.3.3 North America Myasthenia Gravis Market Size by Application (2016-2027)
6.4 North America Myasthenia Gravis Market Size by Country
6.4.1 North America Myasthenia Gravis Market Size by Country (2016-2021)
6.4.2 North America Myasthenia Gravis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Myasthenia Gravis Market Size (2016-2027)
7.2 Europe Myasthenia Gravis Market Size by Type
7.2.1 Europe Myasthenia Gravis Market Size by Type (2016-2021)
7.2.2 Europe Myasthenia Gravis Market Size by Type (2022-2027)
7.2.3 Europe Myasthenia Gravis Market Size by Type (2016-2027)
7.3 Europe Myasthenia Gravis Market Size by Application
7.3.1 Europe Myasthenia Gravis Market Size by Application (2016-2021)
7.3.2 Europe Myasthenia Gravis Market Size by Application (2022-2027)
7.3.3 Europe Myasthenia Gravis Market Size by Application (2016-2027)
7.4 Europe Myasthenia Gravis Market Size by Country
7.4.1 Europe Myasthenia Gravis Market Size by Country (2016-2021)
7.4.2 Europe Myasthenia Gravis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Myasthenia Gravis Market Size (2016-2027)
8.2 Asia-Pacific Myasthenia Gravis Market Size by Type
8.2.1 Asia-Pacific Myasthenia Gravis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Myasthenia Gravis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Myasthenia Gravis Market Size by Type (2016-2027)
8.3 Asia-Pacific Myasthenia Gravis Market Size by Application
8.3.1 Asia-Pacific Myasthenia Gravis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Myasthenia Gravis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Myasthenia Gravis Market Size by Application (2016-2027)
8.4 Asia-Pacific Myasthenia Gravis Market Size by Region
8.4.1 Asia-Pacific Myasthenia Gravis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Myasthenia Gravis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Myasthenia Gravis Market Size (2016-2027)
9.2 Latin America Myasthenia Gravis Market Size by Type
9.2.1 Latin America Myasthenia Gravis Market Size by Type (2016-2021)
9.2.2 Latin America Myasthenia Gravis Market Size by Type (2022-2027)
9.2.3 Latin America Myasthenia Gravis Market Size by Type (2016-2027)
9.3 Latin America Myasthenia Gravis Market Size by Application
9.3.1 Latin America Myasthenia Gravis Market Size by Application (2016-2021)
9.3.2 Latin America Myasthenia Gravis Market Size by Application (2022-2027)
9.3.3 Latin America Myasthenia Gravis Market Size by Application (2016-2027)
9.4 Latin America Myasthenia Gravis Market Size by Country
9.4.1 Latin America Myasthenia Gravis Market Size by Country (2016-2021)
9.4.2 Latin America Myasthenia Gravis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Myasthenia Gravis Market Size (2016-2027)
10.2 Middle East & Africa Myasthenia Gravis Market Size by Type
10.2.1 Middle East & Africa Myasthenia Gravis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Myasthenia Gravis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Myasthenia Gravis Market Size by Type (2016-2027)
10.3 Middle East & Africa Myasthenia Gravis Market Size by Application
10.3.1 Middle East & Africa Myasthenia Gravis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Myasthenia Gravis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Myasthenia Gravis Market Size by Application (2016-2027)
10.4 Middle East & Africa Myasthenia Gravis Market Size by Country
10.4.1 Middle East & Africa Myasthenia Gravis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Myasthenia Gravis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Myasthenia Gravis Introduction
11.1.4 Takeda Revenue in Myasthenia Gravis Business (2016-2021)
11.1.5 Takeda Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Myasthenia Gravis Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 CSL Behring
11.3.1 CSL Behring Company Details
11.3.2 CSL Behring Business Overview
11.3.3 CSL Behring Myasthenia Gravis Introduction
11.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2016-2021)
11.3.5 CSL Behring Recent Development
11.4 Grifols
11.4.1 Grifols Company Details
11.4.2 Grifols Business Overview
11.4.3 Grifols Myasthenia Gravis Introduction
11.4.4 Grifols Revenue in Myasthenia Gravis Business (2016-2021)
11.4.5 Grifols Recent Development
11.5 Alexion Pharmaceutical
11.5.1 Alexion Pharmaceutical Company Details
11.5.2 Alexion Pharmaceutical Business Overview
11.5.3 Alexion Pharmaceutical Myasthenia Gravis Introduction
11.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2016-2021)
11.5.5 Alexion Pharmaceutical Recent Development
11.6 Avadel Pharmaceuticals
11.6.1 Avadel Pharmaceuticals Company Details
11.6.2 Avadel Pharmaceuticals Business Overview
11.6.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction
11.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2016-2021)
11.6.5 Avadel Pharmaceuticals Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Details
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Myasthenia Gravis Introduction
11.7.4 Baxter International Revenue in Myasthenia Gravis Business (2016-2021)
11.7.5 Baxter International Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Myasthenia Gravis Introduction
11.8.4 Novartis Revenue in Myasthenia Gravis Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Myasthenia Gravis Introduction
11.9.4 Bausch Health Revenue in Myasthenia Gravis Business (2016-2021)
11.9.5 Bausch Health Recent Development
11.10 Takeda Pharmaceutical Company
11.10.1 Takeda Pharmaceutical Company Company Details
11.10.2 Takeda Pharmaceutical Company Business Overview
11.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Introduction
11.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2016-2021)
11.10.5 Takeda Pharmaceutical Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Drug Treatment
    Table 3. Key Players of Rapid Immunotherapies
    Table 4. Global Myasthenia Gravis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Myasthenia Gravis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Myasthenia Gravis Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Myasthenia Gravis Market Share by Regions (2016-2021)
    Table 8. Global Myasthenia Gravis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Myasthenia Gravis Market Share by Regions (2022-2027)
    Table 10. Myasthenia Gravis Market Trends
    Table 11. Myasthenia Gravis Market Drivers
    Table 12. Myasthenia Gravis Market Challenges
    Table 13. Myasthenia Gravis Market Restraints
    Table 14. Global Myasthenia Gravis Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Myasthenia Gravis Market Share by Players (2016-2021)
    Table 16. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis as of 2020)
    Table 17. Ranking of Global Top Myasthenia Gravis Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Myasthenia Gravis Product Solution and Service
    Table 21. Date of Enter into Myasthenia Gravis Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Myasthenia Gravis Revenue Market Share by Type (2016-2021)
    Table 25. Global Myasthenia Gravis Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Myasthenia Gravis Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Myasthenia Gravis Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Myasthenia Gravis Revenue Market Share by Application (2016-2021)
    Table 29. Global Myasthenia Gravis Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Myasthenia Gravis Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Myasthenia Gravis Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Myasthenia Gravis Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Myasthenia Gravis Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Myasthenia Gravis Market Size by Country (2016-2021) & (US$ Million)
    Table 36. North America Myasthenia Gravis Market Size by Country (2022-2027) & (US$ Million)
    Table 37. Europe Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Myasthenia Gravis Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Myasthenia Gravis Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Myasthenia Gravis Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Myasthenia Gravis Market Size by Country (2016-2021) & (US$ Million)
    Table 42. Europe Myasthenia Gravis Market Size by Country (2022-2027) & (US$ Million)
    Table 43. Asia-Pacific Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Myasthenia Gravis Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Myasthenia Gravis Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Myasthenia Gravis Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Myasthenia Gravis Market Size by Region (2016-2021) & (US$ Million)
    Table 48. Asia-Pacific Myasthenia Gravis Market Size by Region (2022-2027) & (US$ Million)
    Table 49. Latin America Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Myasthenia Gravis Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Myasthenia Gravis Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Myasthenia Gravis Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Myasthenia Gravis Market Size by Country (2016-2021) & (US$ Million)
    Table 54. Latin America Myasthenia Gravis Market Size by Country (2022-2027) & (US$ Million)
    Table 55. Middle East & Africa Myasthenia Gravis Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Myasthenia Gravis Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Myasthenia Gravis Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Myasthenia Gravis Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Myasthenia Gravis Market Size by Country (2016-2021) & (US$ Million)
    Table 60. Middle East & Africa Myasthenia Gravis Market Size by Country (2022-2027) & (US$ Million)
    Table 61. Takeda Company Details
    Table 62. Takeda Business Overview
    Table 63. Takeda Myasthenia Gravis Product
    Table 64. Takeda Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 65. Takeda Recent Development
    Table 66. F. Hoffmann-La Roche Company Details
    Table 67. F. Hoffmann-La Roche Business Overview
    Table 68. F. Hoffmann-La Roche Myasthenia Gravis Product
    Table 69. F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 70. F. Hoffmann-La Roche Recent Development
    Table 71. CSL Behring Company Details
    Table 72. CSL Behring Business Overview
    Table 73. CSL Behring Myasthenia Gravis Product
    Table 74. CSL Behring Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 75. CSL Behring Recent Development
    Table 76. Grifols Company Details
    Table 77. Grifols Business Overview
    Table 78. Grifols Myasthenia Gravis Product
    Table 79. Grifols Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 80. Grifols Recent Development
    Table 81. Alexion Pharmaceutical Company Details
    Table 82. Alexion Pharmaceutical Business Overview
    Table 83. Alexion Pharmaceutical Myasthenia Gravis Product
    Table 84. Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 85. Alexion Pharmaceutical Recent Development
    Table 86. Avadel Pharmaceuticals Company Details
    Table 87. Avadel Pharmaceuticals Business Overview
    Table 88. Avadel Pharmaceuticals Myasthenia Gravis Product
    Table 89. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 90. Avadel Pharmaceuticals Recent Development
    Table 91. Baxter International Company Details
    Table 92. Baxter International Business Overview
    Table 93. Baxter International Myasthenia Gravis Product
    Table 94. Baxter International Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 95. Baxter International Recent Development
    Table 96. Novartis Company Details
    Table 97. Novartis Business Overview
    Table 98. Novartis Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 99. Novartis Recent Development
    Table 100. Bausch Health Company Details
    Table 101. Bausch Health Business Overview
    Table 102. Bausch Health Myasthenia Gravis Product
    Table 103. Bausch Health Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 104. Bausch Health Recent Development
    Table 105. Takeda Pharmaceutical Company Company Details
    Table 106. Takeda Pharmaceutical Company Business Overview
    Table 107. Takeda Pharmaceutical Company Myasthenia Gravis Product
    Table 108. Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2016-2021) & (US$ Million)
    Table 109. Takeda Pharmaceutical Company Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Myasthenia Gravis Market Share by Type: 2020 VS 2027
    Figure 2. Drug Treatment Features
    Figure 3. Rapid Immunotherapies Features
    Figure 4. Global Myasthenia Gravis Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Other Case Studies
    Figure 8. Myasthenia Gravis Report Years Considered
    Figure 9. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Myasthenia Gravis Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Myasthenia Gravis Market Share by Regions: 2020 VS 2027
    Figure 12. Global Myasthenia Gravis Market Share by Regions (2022-2027)
    Figure 13. Global Myasthenia Gravis Market Share by Players in 2020
    Figure 14. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myasthenia Gravis as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2020
    Figure 16. Global Myasthenia Gravis Revenue Market Share by Type (2016-2021)
    Figure 17. Global Myasthenia Gravis Revenue Market Share by Type (2022-2027)
    Figure 18. North America Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Myasthenia Gravis Market Share by Type (2016-2027)
    Figure 20. North America Myasthenia Gravis Market Share by Application (2016-2027)
    Figure 21. North America Myasthenia Gravis Market Share by Country (2016-2027)
    Figure 22. United States Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Myasthenia Gravis Market Share by Type (2016-2027)
    Figure 26. Europe Myasthenia Gravis Market Share by Application (2016-2027)
    Figure 27. Europe Myasthenia Gravis Market Share by Country (2016-2027)
    Figure 28. Germany Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Myasthenia Gravis Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Myasthenia Gravis Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Myasthenia Gravis Market Share by Region (2016-2027)
    Figure 38. China Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Myasthenia Gravis Market Share by Type (2016-2027)
    Figure 46. Latin America Myasthenia Gravis Market Share by Application (2016-2027)
    Figure 47. Latin America Myasthenia Gravis Market Share by Country (2016-2027)
    Figure 48. Mexico Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Myasthenia Gravis Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Myasthenia Gravis Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Myasthenia Gravis Market Share by Country (2016-2027)
    Figure 54. Turkey Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Myasthenia Gravis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 59. CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 60. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 61. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 62. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 63. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 65. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 66. Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

China Assistive Technologies for Visual Impairment Market Report Forecast 2021 2027
China Assistive Technologies for Visual Impairment Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-11162
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Assistive Listening Device Market Report Forecast 2021 2027
China Assistive Listening Device Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-4Q5981
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Assistive Devices for Vulnerable Groups Market Report Forecast 2021 2027
China Assistive Devices for Vulnerable Groups Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-0V457
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Baby Mats Market Insights Forecast to 2027
Global and United States Baby Mats Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24I3092
Mon Sep 27 00:00:00 UTC 2021

Add to Cart